somatoform
英
美
网络 躯体形式障碍; 躯体型; 躯体形式
双语例句
- Effect of venlafaxine XR in the treatment of persistent somatoform pain disorder
文拉法辛缓释剂治疗躯体形式疼痛障碍疗效观察 - A study on clinical features and nursing care of somatoform disorder patients in comprehensive internal medicine department
综合内科躯体形式障碍病人的临床特点及护理研究 - Clinical study of sertraline in the treatment of somatoform disorders
舍曲林治疗躯体形式障碍的临床研究 - Items and expense of accessory tests and examinations and related factors of somatization disorder and undifferentiated somatoform disorder
躯体化障碍和未分化躯体形式障碍患者辅助检查项目和费用调查 - Comparative Study of Mirtazapine and Citalopram in Treatment of Somatoform Disorder
米氮平与西酞普兰治疗躯体形式障碍的对照研究 - Clinical observation of Somatoform Disorders treated by Bupleurum Granule combined with Dobren tablets
小柴胡颗粒联合舒比利片治疗躯体形式障碍的临床观察 - A study on the characteristics of social function and somatoform symptoms in chronic fatigue syndrome
慢性疲劳综合征患者的社会功能及躯体表现特征的研究 - A control study of hysteric conversion patients and clinical features of somatoform disorders
癔病性躯体障碍与神经官能症躯体形式障碍临床特征对照分析 - A preliminary study of factors of life quality in patients with persist somatoform pain disorder
持续性躯体形式疼痛障碍生命质量的相关因素研究 - Objective: To explore psychological defense mechanism and its related factors in patients with persistent somatoform pain disorder.
目的：对持续的躯体形式的疼痛障碍（以下简称持续疼痛障碍）患者的心理防御机制及相关因素进行研究。 - ( 2) The depressive symptoms of most patients with persist somatoform pain disorder were not severe;
疼痛伴发的抑郁症状严重程度不一，以轻中度为多。 - Objective: To survey the therapeutic effectiveness of venlafaxine in the treatment of persistent somatoform pain disorder.
目的：观察文拉法辛治疗持续性躯体形式疼痛障碍的疗效。 - Defense Mechanism and Its Related Factors in Patients with Persistent Somatoform Pain Disorder
持续的躯体形式的疼痛障碍患者的防御机制及相关因素研究 - Conclusion CCMD-3 has admited and formulated the diagnosis standard of somatoform disorders and it can increase the rate of patients 'diagnosis and can decrease patients' cost.
结论CCMD-3已经承认和制订了躯体形式障碍的诊断标准，它可以提高病人的诊断和治愈率，并减少病人的经济支出。 - Conclusions The psychotic disorders as well as seen in patients in general hospital are hypochondriasis and somatoform disorder, and depression of the female.
结论综合医院理精神障碍患者的主要问题均为疑病躯体化障碍，女性主要为抑郁。 - Conclusion Fluoxetine hydrochloride has notable efficacy, higher safety and better compliance in the treatment of persistent somatoform pain disorder.
结论氟西汀治疗持续性躯体形式疼痛障碍疗效显著，安全性高，依从性好。 - Methods 62 patients with persistent somatoform pain disorder were treated with fluoxetine hydrochloride 20mg/ d for 6 weeks.
方法对62例持续性躯体形式疼痛障碍患者应用氟西汀20mg。 - Objective: To explore the quality of life of patients with persist somatoform pain disorder ( PSPD) and its relative factors.
目的探讨持续性躯体形式疼痛障碍（persistsomatoformpaindisorder，PSPD）患者的生命质量及相关因素。 - The Clinical Analysis of Somatoform Disorders ( SDs) in Community Health Care Institution
社区保健机构中躯体形式障碍的临床分析 - Objective: To explore the characteristics of social function and somatoform symptoms in chronic fatigue syndrome ( CFS).
目的：调查分析慢性疲劳综合征患者（CFS）的社会功能状态及躯体表现的特征，为健康干预提供理论依据。 - 139 neurotic patients and 30 patients with somatoform disorders who were referred to the Department of Psychiatry were tested with MMPI ( Chinese revised version).
用中国修订版MMPI测试了首诊于精神科门诊的神经症病人139例，非精神科转诊的躯体形式障碍病人30例。 - Clinical Features and Treatment of Somatoform Disorders in Internal Medicine Department
内科门诊躯体形式障碍的临床特征和治疗研究 - Methods: The scale of anxiety symptom checklist, the scale of depressive symptom checklist and the self-contrivable scale of clinical features were used in 26 cases of hysteric conversion sufferes and 24 cases of patients with somatoform disorders.
方法采用焦虑、抑郁症自评量表（SAS、SDS）以及自编临床特征调查表分别对26例癔病性躯体障碍和24例躯体形式障碍患者进行调查分析。 - Objective To study the efficacy of paroxetine in the patients with persist somatoform pain disorder.
目的研究帕罗西汀对持续的躯体形式疼痛障碍（以下简称持续疼痛障碍）的疗效。 - Objective To observe therapeutic effect of electroacupuncture combined with moving cupping therapy on somatoform disorders.
目的：观察电针配合走罐治疗躯体形式障碍的临床疗效。 - Somatoform symptom of the patients somatoform symptom can reflect the psychological state.
患者说的躯体症状能反映心理状态。 - Somatoform symptoms is anxiety somatization performance and its influencing factors.
躯体症状既是焦虑的躯体化表现，也是其影响因素。